- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Craciun A, Rusu A, Craciun CI, Bala C, Roman G, Veresiu IA, Georgescu CE
Changes in Body Composition after Three Months of Insulin Therapy in Type 2 Diabetes - A Cohort Retrospective Study
Acta Endo (Buc) 2015, 11 (3): 312-318doi: 10.4183/aeb.2015.312
Objectives. The objective of this retrospective
study was to evaluate weight gain at 3 months following
insulin therapy initiation and to determine if it is due to fat or
fat free tissue.
Methods. Fifty-eight patients with T2DM
and initiation of insulin therapy were evaluated. Body
composition was assessed with InBody720 device (Biospace,
Korea) before and 3 months after the initiation of insulin
therapy.
Results. The insulin therapy was initiated with
basal insulin in 84.48% of the cases. The initial dose of
insulin was 22.76±12.89 units/day and increased at 3 months
to 30.81±18.49 units/day (p<0.001). The initial HbA1c was
9.86±2.02% and decreased to 7.58±1.19% (p<0.001). The
body weight increased from 87.01±17.37 kg to 88.04±16.64
kg (p=0.026). The fat body mass and the percent of fat
decreased with no statistical significance; the intracellular
and extracellular body water increased significantly
(intracellular: 26.30±5.96 vs. 27.26±6.16; extracellular:
16.61±3.63 vs. 17.03±3.84; p<0.001).
Conclusion. During the first 3 months after
initiation of insulin therapy a modest weight gain due to
increase in the body water after restoration of the metabolic
balance was observed.
Keywords: type 2 diabetes, insulin therapy, weight gain, fat mass, fat free mass, glycemic control, insulin.
Correspondence: Anca Craciun MD, “Iuliu Hatieganu” University of Medicine and Pharmacy - Diabetes, Nutrition and Metabolic
Diseases, 2 Clinicilor Street, Cluj Napoca, Cluj, 400006, Romania, E-mail: anca.craciun@umfcluj.ro